Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-01-10
2010-12-14
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
07851598
ABSTRACT:
Method of identifying a modulator of CD28 comprising comparing a structural model of a candidate modulator with a structural model of CD28 to thereby determine whether the modulator will bind to CD28, wherein the structural model is derived from, or comprises, structural coordinates of a crystal of: (i) CD28, (ii) a fragment of CD28, or (iii) a homologue of (i) or (ii). The crystal of CD28 in a soluble form complexed with the Fab fragment of a mitogenic (superagonistic) antibody has been obtained and used for the determination of the 3D-structure of the receptor. The application also relates to modulators of superagonistic signalling for any receptor of the CD28 family, i.e. to superagonistic antibodies and chimeric proteins thereof, and to the screening of the superagonistic modulators. In the methods of screening, the binding of the candidate modulators to a portion of the receptor proximal to the cell membrane is investigated.
REFERENCES:
patent: 2002/0160000 (2002-10-01), Wood et al.
patent: 2003/0166860 (2003-09-01), Hunig et al.
patent: 2004/0092718 (2004-05-01), Hunig
patent: 2006/0121021 (2006-06-01), Hunig
patent: WO 03/078468 (2003-09-01), None
patent: WO 03/095487 (2003-11-01), None
patent: WO 2004/004768 (2004-01-01), None
patent: WO 2005/066867 (2005-07-01), None
Watkins et al., J. Virology, 1996, 70: 8431-8437.
Linsley, P. S. “New Look at an Old Costimulator”,Nature Immunology, Mar. 2005, pp. 231-232, vol. 6, No. 3.
Lühder, F. et al. “Topological Requirements and Signaling Properties of T Cell-Activating, Anti-CD28 Antibody Superagonists”,J. Exp. Med., Apr. 21, 2003, pp. 955-966, vol. 197, No. 8.
Stamper, C. C. et al. “Crystal Structure of the B7-1/CTLA-4 Complex that Inhibits Human Immune Responses”,Nature, Mar. 29, 2001, pp. 608-611, vol. 410.
Chang, C.Y. Y. et al. “Crystallization and preliminary X-ray analysis of CTLA-4 (CD152) membrane-external domain”,Acta Cryst., Section D, 2000, pp. 1468-1469, vol. D56.
Zhang, X. et al. “Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2”,Acta Cryst., Section D, 2001, pp. 898-899, vol. D57.
Schwartz, J.-C. D. et al. “Structural basis for co-stimulation by the human CTLA-4/B7-2 complex”,Nature, Mar. 29, 2001, pp. 604-607, vol. 410.
Evans, E. J. “Crystal structure of a soluble CD28-Fab complex”,Nature Immunology, Mar. 2005, pp. 271-279, vol. 6, No. 3.
Isis Innovation Limited
Ouspenski Ilia
Saliwanchik Lloyd & Saliwanchik
LandOfFree
Receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4215927